CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial.

ABSTRACT:

Objectives

The authors investigated the impact of coronary artery bypass grafting (CABG) on first and recurrent hospitalization in this population.

Background

In the STICH (Surgical Treatment for Ischemic Heart Failure) trial, CABG reduced all-cause death and hospitalization in patients with and ischemic cardiomyopathy and left ventricular ejection fraction <35%.

Methods

A total of 1,212 patients were randomized (610 to CABG + optimal medical therapy [CABG] and 602 to optimal medical therapy alone [MED] alone) and followed for a median of 9.8 years. All-cause and cause-specific hospitalizations were analyzed as time-to-first-event and as recurrent event analysis.

Results

Of the 1,212 patients, 757 died (62.4%) and 732 (60.4%) were hospitalized at least once, fo

SUBMITTER: Howlett JG 

PROVIDER: S-EPMC7375257 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature